No additional protection for new formulations of old active ingredients
In March 2017, the High Court in the UK requested a preliminary ruling from the CJEU on the interpretation of Article 3(d) of the SPC Regulation (EC/469/2009). In particular, the following question was referred:- “Is Article 3(d) of the SPC Regulation to be interpreted as permitting the grant of an SPC where the marketing authorisation...
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan and Actavis Group PTC – Part II
The Test for Infringement of a Patent for Manufacturing for a Limited Use Background On 14th November 2018 the UK Supreme Court (UKSC) handed down its judgment in the case of Warner-Lambert Company LLC v Generics (UK) Ltd and Actavis Group PTC. The case concerned a drug called pregabalin, which is an analogue of gamma...
Warner-Lambert Company LLC v Generics (UK) Ltd t/a Mylan and Actavis Group PTC – Part I
Construction, Abuse of Process and Insufficiency Background On 14th November 2018 the UK Supreme Court (UKSC) handed down its judgment in the case of Warner-Lambert Company LLC v Generics (UK) Ltd and Actavis Group PTC. The case concerned a drug called pregabalin, which is an analogue of gamma aminobutyric acid (GABA), a neurotransmitter. Pregabalin was...
Boult Wade Tennant’s Brexit Toolkit
Following the latest developments with Brexit, and now that the no-deal Brexit deadline has moved to 31 October 2019, we have updated our Brexit Toolkit which can be found here. This toolkit provides pertinent information to all types of businesses, allowing effective preparation for Brexit when it occurs.
The technical nature of simulation methods – A New Referral to the Enlarged Board of Appeal
In decision T0489/14, the EPO Boards of Appeal have made a new referral to the Enlarged Board of Appeal regarding the patentable nature of computer-implemented simulation methods. Under European practice, methods implemented on a computer are only considered patentable if the method can be understood to have a “technical effect”. In particular, methods that are...
Attendee: Rohan Setna
CIPA Congress 2019, September, London
MIP International Patent Forum 2019, March , London
Attendee: Dr. Isabel Blanco
MOMAD, Fashion Fair, Madrid, 8-10 February.
INTA Annual Meeting , Boston, May 2019
Attendee: Nigel Tucker
Southern Manufacturing and Electronics trade show, Farnborough, February 5th 2019
Attendee: Joshua McFarlane
Queen Mary University of London Career Events, December 2018
Attendee: Joanna Peak
Intellectual Property Case Law Seminar
Attendee: Susi Fish
MIP International Women’s Leadership Forum
Attendee: Nigel Tucker
Advanced Engineering 2018
Attendee: Edward Ronan
Westminster Health Forum Keynote Seminar: The future of biosimilars in the UK – innovation, regulation and increasing uptake
In this edition we take a look at the EUIPO’s decision on the invalidity of a three-stripe mark by Adidas; G4S PLC’s successful opposition to an application by F & G Kites Limited; a useful reminder of the evidence required when defending a registration that has been challenged on the grounds of non-use; the 4th Latin American country that will be joining the Madrid Protocol; and a new rule introduced by the US Patent and Trademark Office.
Read about latest developments in the Trade Marks field, as well as what’s going on with the team here at Boult Wade Tennant
In this edition we caution brand owners about applications by Gleissner; look at a modern day David and Goliath story involving McDonald’s and Irish rival Supermac’s; cover recent changes to UK TM law to be aware of; Canada’s new trade mark law coming into force later this year; and the latest developments in the Cadbury V Nestlé chocolate wars.
Guest posts from other sources. Clicking on the links will take you to an external site.